LIMINATUS PHARMA, INC. (LIMNW) Operating income 2024–2025
LIMINATUS PHARMA, INC. (LIMNW) annual operating income history from SEC filings — each fiscal year as reported.
-$3.0MFY2025 · since FY2024: -$3.3M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | +10.9% |
| FY2024 | -$3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LIMNW financial trends
LIMNW RevenueLIMNW Net incomeLIMNW Net marginLIMNW Gross profitLIMNW Gross marginLIMNW Operating marginLIMNW Operating cash flowLIMNW Free cash flowLIMNW Capital expendituresLIMNW Return on equityLIMNW Stock buybacksLIMNW Dividends paidLIMNW Total assetsLIMNW Total liabilitiesLIMNW Shareholders’ equityLIMNW overview →